`
`Device support options
`
`
`
`Left atrium support
`
`I dwu'k | x’uu 1.1mm
`
`LiuapL |.I‘V("I nu. w,
`
`‘
`
`.11“ um. ll."<l|‘l.ll"
`
`N
`
`Edwards Lifesciences v. Boston Scientific Scimed
`
`IPR2017-00060 U.S. Patent 8,992,608
`
`Highly Confidential
`
`PROTECTIVE ORDER MATERIAL
`
`EDWARDS 01033802
`
`
`
`,
`
`- Manufacturin Technolo-
`
`
`
`_ Anchoring locations
`
`~
`
`Left ventricle support
`
`.ii‘iu." I-i.:i: ‘1 arm 1
`
`
`'I'Iivmi i~l ir"flil‘l‘l“~
`‘
`L
`
`lli\\i|lli\i |I"\(IIHI‘I'~
`
`b)
`
`Edwards Lifesciences v. Boston Scientific Scimed
`
`IPR2017-00060 U.S. Patent 8,992,608
`
`
`Highly Confidential
`
`PROTECTIVE ORDER MATERIAL
`
`EDWARDS 01033803
`
`
`
`
`
`
`I‘qum- ~ I
`ifs-m It Iii'l“
`(,ll\\.lll1> inil‘ul’iil“!
`
`I
`
`Requirements
`> (Simulator and valve fixture)
`
`Functionality simulator
`
`i:1\\.II'i-Li?r~=r:u -.~
`
`: ‘lnm‘rx I xiv-av If!"
`
`IPR2017-00060 U.S. Patent 8,992,608
`
`
`Edwards Lifesciences v. Boston Scientific Scimed
`
`Highly Confidential
`
`7 PROTECTIVE ORDER MATERIAL
`
`EDWARDS 01033804
`
`
`
`
`
`ni\\.‘IlV1-| \h'n mu m
`
`, Full device deployment
`
`H Simulator tests summery
`
`xv. rum-nu .. nu lumng mum-.1
`
`
`
`l“‘\\.n I~ Hi ~. :rm ‘w
`
`(JI
`
`Edwards Lifesciences v. Boston Scientific Scimed
`
`IPR2017-00060 U.S. Patent 8,992,608
`
`
`Highly Confidential
`
`PROTECTIVE ORDER MATERIAL
`
`EDWARDS 01033805
`
`
`
`Pilot animal study results
`
`
`
`Feasibility Tests Status
`
`”luau ~ Ijil ~l‘n'tIn-s
`
`Edwards Lifesciences v. Boston Scientific Scimed
`
`IPR2017-00060 U.S. Patent 8,992,608
`
`Highly Conficential
`
`'
`
`"
`
`"
`
`PROTECTIVE ORDER MATERIAL
`
`EDWARDS 01033806
`
`
`
`Updated Schedule
`
`'
`
`‘
`
`l':li\\'flrll~l.l["ii'lllll'l'>
`
`i l'.<|v~.mlaLiirwu'm‘m
`
`.~
`
`d
`'~.
`.
`,‘.
`‘
`'
`J
`_ .
`>
`l
`fififl‘g‘mJet
`
`Me
`
`A
`,.
`
`r"
`
`Edwards
`
`Helping Patients Is Our Life's Work. and
`
`00 71"},
`
`7
`
`Edwards Lifesciences v. Boston Scientific Scimed
`
`
`
`Highly Confidential
`
`7
`
`lPR2017-00060 U.S. Patent 8,992,608
`
`Exhibit 2042 - Part 2
`PROTECTIVE ORDER MATERIAL
`
`Page 26 of 44
`EDWARDS 01033807
`
`
`
`
`
`
`
`Project definition
`
`l‘:( wards
`
`.‘Jolarw Emercu
`'JorF'WE
`
`Edwunisljfcwicnms
`
`First Concept (From 3.Rowe)
`
`First concept (cont.)
`
`lwlwrda Ulrmrm-n
`
`Ed‘nrdi l .ilr mu- nr-c
`
`First concept
`
`Highly Confidential
`
`Edwards Lifesciences v. Boston Scientific Scimed
`
`IPR2017-00060 U.S. Patent 8,992,608
`Exhibit 2042 - Part 2
`
`PROTECTIVE ORDER MATERIAL
`
`Page 27 of 44
`EDWARDS 01033808
`
`
`
`Mum: I Uni-mirr-
`
`Doctors’ Inputs summary
`
`.
`
`More issues to consider
`
`
`
`
`
`Our ideas
`
`lid! hula iii-minim:
`
`Eh an: leaclt‘lk‘c!
`
`ltdurmis ljm-n acts
`
`Edmunfi Dix-mums
`
`Edwards Lifesciences v. Boston Scientific Scimed
`
`2
`
`IPR2017-00060 U.S. Patent 8,992,608
`
`Highly Confidential
`
`PROTECTIVE ORDER MATERIAL
`
`EDWARDS 01033809
`
`
`
`l': immi: Ulrwiucr:
`
`
`
`E<1Innhl.:l4:scimcve
`
`Edwards Lifesciences v. Boston Scientific Scimed
`IPR2017-00060 U.S. Patent 8,992,608
`
`3
`
`Highly Conficential
`
`PROTECTIVE ORDER MATERIAL
`
`EDWARDS 01033810
`
`
`
`1" concept phase decisions’hnd results-
`
`l: “unis ”limit-m (-
`
`
`
`More issues to complete feasibility
`
`Eduard: Lch 9:»: Mt:
`
`Edwards Lifesciences v. Boston Scientific Scimed
`IPR2017-00060 U.S. Patent 8,992,608
`
`4
`
`Highly Conficential
`
`" PROTECTIVE ORDER MATERIAL
`
`EDWARDS 01033811
`
`
`
`Future activities & Timetable
`
`Closing Slide
`
`Edwud: Ukwicchi
`
`l‘kiwards
`
`Helping patients is our life's wok. and
`
`00
`
`Edward; Lifucwnccs
`
`
`
`Highly Confidential
`
`'
`
`'
`
`Exhibit 2042 - Part 2
`PROTECTIVE ORDER MATERIAL
`
`Page 31 0f44
`EDWARDS 01033812
`
`Edwards Lifesciences v. Boston Scientific Scimed
`lPR2017-00060 U.S. Patent 8,992,608
`
`5
`
`
`
`Background
`
`Edwards
`
`Project Status
`
`Jar Pau’ea
`any 3: as
`
`W
`.
`..
`.
`:(‘Iilds lifrxrnct:
`
`Objectives
`
`Technical requirements
`
`
`
`hlhunlu LII”: mm
`
`v
`:‘i'lillis ljfrx (nvr‘
`
`_ Development process
`
`Development process (cont)
`
`Edwdl'da “Inc was
`
`Eduard; Lifcsccncu
`
`Edwards Lifesciences v. Boston Scientific Scimed
`lPR2017-00060 U.S. Patent 8,992,608
`
`1
`
`i HighTy Confidential
`
`PROTECTIVE ORDER MATERIAL
`
`EDWARDS 01033813
`
`
`
`Development process (cont)
`
`Interim Device
`
`i-iuuni- ijlru-iwmr»
`
`Friannis I .iim‘lrnrrs
`
`PhasedApproach
`
`>
`
`,
`
`.
`
`.
`
`New Grip-Design
`
`
`
`Diver-13.:
`
`New Grip Design (Cont)
`
`Proposed Schedule
`
`himmi: ijicunm-rs
`
`Mann}: Liimu‘nm
`
`Edwards Lifesciences v. Boston Scientific Scimed
`
`2
`
`lPR2017-00060 U.S. Patent 8,992,608
`
`Highly Confidential
`
`PROTECTIVE ORDER MATERIAL
`
`EDWARDS 01033814
`
`
`
`Edwards Lifesciences v. Boston Scientific Scimed
` IPR2017-00060 U.S. Patent 8,992,608
` Exhibit 2042 - Part 2
` PROTECTIVE ORDER MATERIAL
`
`Page 34 of 44
`
`
`
`ELS |L Role
`as an
`
`R&D Center
`
`1x:iu.:nԤ\i ill-n i.~i.-.~-
`
`
`
`Our Competencies
`
`L_
`
`7 Our Vision
`
`I.|n.arii~l.tfr~i'iu- u m
`
`KG”
`
`> Oroanizational Chart
`
`
`
`
`
` hivunh Lift-w "‘hl‘l'\
`
`
`
`Edwards Lifesciences v. Boston Scientific Scimed
`
`IPR2017-00060 U.S. Patent 8,992,608
`
`Highly Confidential
`
`Exhibit 2042 - Part 2
`,,,
`PROTECTIVE ORDER MATERIAL
`
`Page 35 of 44
`EDWARDS 01033816
`
`
`
`Relationship Models
`
`Key Success Factors
`
`Mum-l: l iiiv-i'n'm'v:
`
`.il\\.,rii.~'
`
`1 HM n-u- r~
`
`
`
`Customer Commitment
`
`
`
`Design Transfer
`
`Improvement Project
`
`Assat‘Bash Lakscn Sirimunc
`
`May 2006
`
`I‘rhmnhl iivmirimw
`
`4.“;11'x l if
`
`Design Transfer Project Objective
`
`. Pr0ject Team
`
`laiimurl ~[ lr"'-\l"li|l :
`
`lilmuil- I ilv's: ll‘n r~
`
`L)
`
`Edwards Lifesciences v. Boston Scientific Scimed
`
`Highly Confidential
`
`IPR2017-00060 U.S. Patent 8,992,608
`
`Exhibit 2042 - Part 2
`PROTECTIVE ORDER MATERIAL
`
`Page 36 0f 44
`EDWARDS 01033817
`
`
`
`Pro’ect Outline
`
`Today’s Structure
`
`
`
`'1 zu'get: Q4/2006
`iiiimrnis{Jib-(1.1mm
`
`3}]an uiivsm'm v.~
`
`Activities & Schedule
`
` .S'cam/css Hans/er
`
`— N0 Headache
`.
`—~ More Pro/eels
`
`
`
`
`
`lithvmis
`‘
`. M
`wepng Datlentszs cur liic‘: workarc
`M”
`
`xi\\.m~: lh-vlflur.‘
`
`9)
`
`Edwards Lifesciences v. Boston Scientific Scimed
`
`
`
`Highly Confidential
`
`,
`
`IPR2017-00060 U.S. Patent 8,992,608
`
`Exhibit 2042 - Part 2
`PROTECTIVE ORDER MATERIAL
`
`Page 37 of 44
`EDWARDS 01033818
`
`r“
`
`‘
`
`,‘i“.’ Mi» i.|2r<uun1m
`I ii\\.‘xrihi.l‘t‘»(ii-nrm
`
`
`
`
`
`6L8€€OLO SOHVMGEI
`
`neuuapuuoo Muffin—1
`
`ijlmm Spaniel
`uny zoos
`
`I'liunuL l.![«\‘il'lhi‘-
`
`Development- process —
`
`
`
`Packaging ,-. Tray
`
`i(i\\.i:«l~ lJrn-w'irnw-
`
`Edwards Lifesciences v. Boston Scientific Scimed
`lPR2017-00060 U.S. Patent 8,992,608
`
`1
`
`PROTECTIVE ORDER MATERIAL
`
`
`
`OZSSSOLO SGHVMGE]
`
`
`, fl
`|euuapuuoo AmfigH
`
`7
`
`7
`
`V
`
`Logistic plan" A
`
`Time frame
`
`‘
`
`151“,” L I.|fl‘~4 Hut-J
`
`Work to be_ none in Irvine
`
`Qualification-tests
`
`
`
`'LuuhL |.i[v~4'ir|:(r-
`
`1'i\\.|1:[~ I.I[v'~x i'lu't'~
`
`Cost update i.
`
`Regulatory gndiClinical plan
`
`-: “41 Ll Ifx'w i‘m x\
`
`h “mil‘ I Hm. mum
`
`Edwards Lifesciences v. Boston Scientific Scimed
`
`IPR2017-00060 U.S. Patent 8,992,608
`
`’)
`
`PROTECTIVE ORDER MATERIAL
`
`
`
`
`
`LZQSCOLO SGHVMGE
`
`
`,
`leuuepuuoa AlufigH
`
`fl
`
`Schedule
`
`Document List
`
`I'iémn'IL l.1fr.~(‘lvm‘m
`
`lailmird~ l .lll"l‘ll‘llv w
`
`
`
`Edwards
`~1eip ng cements |S our Me‘s work, are W W6“,
`
`.‘ I'dnanh Lilm'ivnq'v-
`
`‘
`
`i,
`
`' l"(!\\.u'l|\l.ifq-~i irnrrs
`
`Edwards Lifesciences v. Boston Scientific Scimed
`lPR2017-00060 U.S. Patent 8,992,608
`
`Exhibit 2042 - Part 2
`PROTECTIVE ORDER MATERIAL
`
`q
`3
`
`Page 40 of 44
`
`
`
`
`
`
`
`
`
`
`
`
`Ball: Fallon
`May 2006
`
`:. 'Z‘l“l“ll‘l lIi'“ ii-iii.-~
`
`Why PHV 20mm?
`
`Product Specifications
`
`
`
`:i
`
`.‘X‘imnh |.i1>l"i'll'1l|1'\
`
`‘ 1:: l‘lluunhI.Ifi'~i‘ii'liir3
`
`In Vitro Tests
`
`In Vitro Tests
`
`,
`
`-,1' I:1'“illlj\lJrl"lll'l|il'~
`
`Edwards Lifesciences v. Boston Scientific Scimed
`IPR2017-00060 U.S. Patent 8,992,608
`
`
`1
`
`Highly Confidential
`
`PROTECTIVE ORDER MATERIAL
`
`’” '
`
`EDWARDS 01033822
`
`
`
`
`
`Highly Confidential
`
`Edwards Lifesciences v. Boston Scientific Scimed
`
`IPR2017-00060 U.S. Patent 8,992,608
`
`Page 42 014A
`EDWARDS 01033823
`
`Exhibit 2042 - Part 2
`PROTECTIVE ORDER MATERIAL
`
`
`
`In Vitro Preliminary Results
`
`Regulatory and Clinical Plan
`
`,[IIWHILLirr-L'n’uu’a
`
`n 5‘ l‘dunnl‘l‘ifi'u iu-ixm"
`
` '.
`
`-'.
`
`'iiuunls lvih-«i-n-uun
`
`Open lssues~
`
`. H}.
`'..;
`
`'
`
`'
`I
`r
`ni\\.-|'II~ | ,l!l'~i irunw
`
`»
`l
`1
`”I; Lllmilihth-u “'le
`
`‘
`
`Edwards Lifesciences v. Boston Scientific Scimed
`lPR2017-00060 U.S. Patent 8,992,608
`
`3
`
`*7
`Highly Confidentiali— ’
`
`Exhlblt 2042 - Part 2
`PROTECTIVE ORDER MATERIAL
`
`Page 43 of 44
`EDWARDS 01033824
`
`
`
`
`
`
`
`Activities and timetable
`
`i
`
`Edwards
`
`m i',l.i\\i|"|\ Liiru ii'uu'w
`
`Helping patients is our nlo's work, and
`
`(,0
`
`‘g M .l Mluh LIM‘u‘N‘lI! rs
`
`Edwards Lifesciences v. Boston Scientific Scimed
`lPR2017-00060 U.S. Patent 8,992,608
`
`3
`
`Highly Confidential
`
`Exhibit 2042 - P_a[t g
`PROTECTIVE ORDER MATERIAL
`
`Page 44 of 44
`EDWARDS 01033825
`
`